Basic Prostate Cancer Guide: Find out Myths and Truths About the Second Leading Cause of Men's Cancer Death.
Prostate cancer is second most common in men, second after non-melanoma skin cancer. In 2018, according to the National Cancer Institute (INKA), more than 68 thousand new cases, highlighting the urgency to clarify doubts about such a problem and to increase its early detection, making the improvement of the quality and life of Brazilians a priority.
The prostate is the largest gland supplement in the male genital system. It lies under the urinary bladder in front of the rectum and surrounds the urethra. Prostate fluid produced by it accounts for about 20% of the volume of the seed and is intended for sperm nutrition.
We can quote how risk factors advanced age, presence of family history and excess body fat. However, it is necessary to clarify that the absence of these factors did not release the individual from cancer. It is also worth noting that a low-fat, balanced diet associated with physical activity and habits of not drinking or smoking are fundamental to reduce the risk of cancer, among other chronic non-communicable diseases, such as hypertension and diabetes.
Some typical symptoms are common in patients with advanced prostate cancer, such as: difficulty urinating, decreased urine output, and urgency withdrawal. However, we can make a differential diagnosis with other disorders, such as benign prostatic hyperplasia and prostatitis.
Prostate cancer can be identified by combining two tests: rectal touch and dosage of a specific prostatic antigen (PSA) Blood
The touch allows the doctor to palpate the nodules or hardened tissues in the gland, which often indicates cancer in them. the early stages and with that better forecast especially if a patient is selected. proper management of cancer.
PSA is generally a great test for identifying such prostate changes. But sometimes normal levels can hide advanced cancer and in others, altered levels do not close the diagnosis. Thus, it is necessary to follow the pre-test instructions to improve its accuracy.
Therefore, the urologist can order tests complementary, such as biopsy and, more recently, Multiparametric magnetic resonance imaging, which enables greater precision in the detection and characterization of prostate tumors, but is still being tested for its efficacy and carries a high cost to the patient. It is necessary to emphasize that such complementary exams don't spray touch, no PSA.
So when does one need to go to the urologist to be safe?
The Brazilian Society of Urology (SBU) and INKA find it imperative individualize the therapeutic approach and consider age and other relevant factors, such as ethnicity (because the cancer affected affects more black men), family history, and other specific features of prostate cancer.
Thus, the SBU stipulates that men 50 and older should go to a urologist and perform individual clinical assessment. For black men or first-degree relatives of men with cancer, screening should begin at age 45. It should be noted that screening will only take place after a a broad discussion of the risks and potential benefits, related to the professionalism of the chosen physician.
The treatment can basically be through surgery, radiotherapy or their association. However, it does create many impacts on the life of the individual, making the case a necessary assessment. Treatment will be indicated if any disease progression and if the infected person has a life expectancy greater than 10 years. Thus, slow-growing tumors do not experience the undesirable effects of treatment. Finally, talk to your urologist about clarify any doubts before any examination or treatment It is essential, first of all, to ensure patient autonomy and to guarantee the best possible quality of life.